Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Terephthalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.55 |
| ▸ | CA1 | P00915 | 4/20 | 0.52 |
| ▸ | CA2 | P00918 | 4/20 | 0.52 |
| ▸ | CA12 | O43570 | 3/20 | 0.52 |
| ▸ | CA9 | Q16790 | 3/20 | 0.52 |
| ▸ | CA3 | P07451 | 2/20 | 0.52 |
| ▸ | CA6 | P23280 | 2/20 | 0.52 |
| ▸ | CA5A | P35218 | 2/20 | 0.52 |
| ▸ | CA7 | P43166 | 2/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.52 |
| ▸ | TYR | P14679 | 1/20 | 0.52 |
| ▸ | DRD1 | P21728 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | DAO | P14920 | 1/20 | 0.50 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzoic Acid SCHEMBL14938995 | 0.90 | TSHR (0.67) | TSHRTP53SRD5A2CA1CA12 | |
| SCHEMBL607731 | 0.84 | EPHX2 (0.58) | TSHRTP53CA1CA2CA12 | |
| SCHEMBL72425 | 0.82 | MPO (0.67) | TSHRTP53SRD5A2CA1CA2 | |
| Terephthalic Acid SCHEMBL11875483 | 0.82 | TSHR (0.60) | TSHRTP53SRD5A2CA1CA2 | |
| Isophthalic Acid SCHEMBL1000200 | 0.81 | CYP1A2 (0.61) | TSHRCA1CA2CA12CA9 | |
| Terephthalic Acid SCHEMBL11858116 | 0.80 | TSHR (0.86) | TSHRTP53SRD5A2CA1CA2 | |
| Terephthalic Acid SCHEMBL27400233 | 0.80 | TSHR (0.86) | TSHRTP53SRD5A2CA1CA2 | |
| Terephthalic Acid SCHEMBL1655 | 0.80 | TSHR (1.00) | TSHRTP53SRD5A2CA1CA2 | |
| Terephthalic Acid SCHEMBL5053781 | 0.80 | TSHR (1.00) | TSHRTP53SRD5A2CA1CA2 | |
| Terephthalic Acid SCHEMBL175823 | 0.80 | TSHR (1.00) | TSHRTP53SRD5A2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7868102-B2 | Method for producing a film of an aromatic amide oxadiazole polymer containing an oxadiazole structure and the film so produced | TORAY INDUSTRIES, INC. (JP) | 2011-01-11 | — | — | US | disclosed |
| EP-1602680-B1 | AROMATIC POLYMER, FILM, ELECTROLYTE MEMBRANE AND SEPARATOR | TORAY INDUSTRIES (JP) | 2010-12-22 | — | — | EP | disclosed |
| EP-2258746-A2 | A method for producing an aromatic polymer, film, electrolyte membrane and separator | Toray Industries, Inc. (JP) | 2010-12-08 | — | — | EP | disclosed |
| US-20100016521-A1 | Method for producing a film of an aromatic amide oxadiazole polymer containing an oxadiazole structure and the film so produced | MORIYAMA HIDEKI | 2010-01-21 | — | — | US | disclosed |
| US-20090182171-A1 | Compound having oxadiazole structure and a dehydration-cyclization method for producing the same | MORIYAMA HIDEKI | 2009-07-16 | — | — | US | disclosed |
| US-7511112-B2 | Aromatic polymer, film, electrolyte membrane and separator | TORAY INDUSTRIES, INC. (JP) | 2009-03-31 | — | — | US | disclosed |
| US-20060204812-A1 | Aromatic polymer, film, electrolyte membrane and separator | MORIYAMA HIDEKI | 2006-09-14 | — | — | US | disclosed |
| EP-1602680-A1 | AROMATIC POLYMER, FILM, ELECTROLYTE MEMBRANE AND SEPARATOR | TORAY INDUSTRIES, INC. (JP) | 2005-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090182171-A1 | Compound having oxadiazole structure and a dehydration-cyclization method for producing the same | OGFOD1, ODC1, OTC | TSHR 1648/4885TP53 1253/4885SRD5A2 461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.